Coming in at over 200 pages, today’s National Academy of Sciences (NAS) report, 'Gene Drives on the Horizon’ is weighty but disappointing. It fails to properly address three of the most pressing issues raised by the controversial new technology of CRISPR-CAS9 gene drives. Dubbed, the ‘mutagenic chain reaction’ by its inventors, RNA-guided gene drives are a high-leverage synthetic biology technology invented only last year.
Genomics & Biotechnology
ETC Group has tracked developments in the genetic engineering of plants, animals and microorganisms since the early 1980s and tracked the transition of the biotechnology industry into a broader 'life sciences' industry spanning agriculture, pharmaceuticals, energy and chemicals production. Today, biotechnology encompasses a variety of techniques that involve the use and manipulation of living organisms to make commercial products (including cell and tissue culture, recombinant DNA technology and synthetic biology). Underlying the commercial manipulation of life are ever more powerful genomics technologies (gene-mapping) that enable companies to quickly 'read,' store and digitally analyze genetic information -- either of single organisms or entire ecosystems (known as metagenomics). ETC Group (then RAFI) was one of the first organizations to warn of the downside of genetic engineering of crops and livestock and has since kept an eye on developments in human biotech, synthetic biology, biowarfare and industrial biotech.